Understanding Alzheimer’s Disease and Dementia

Mar 25, 2025

Alzheimer Disease and Dementia

Overview of Dementia

  • Not a disease: Refers to a set of symptoms, such as poor memory and difficulty in learning new information.
  • Causes: Often results from damage to brain cells due to various diseases.

Alzheimer Disease

  • Most common cause of dementia.
  • Type: Neurodegenerative disease that leads to loss of neurons in the brain, especially in the cortex.

Causes and Pathophysiology

Amyloid Plaques

  • Amyloid Precursor Protein (APP):
    • Located in the neuron's cell membrane.
    • Assists in neuron growth and repair.
    • Usually broken down by alpha and gamma secretases.
  • Problematic Enzyme Processing:
    • Beta secretase teams up with gamma secretase, creating insoluble amyloid beta monomers.
    • Monomers form beta-amyloid plaques outside neurons, hindering neuron signaling and possibly causing inflammation.
    • Plaques can also lead to amyloid angiopathy, weakening blood vessel walls, increasing hemorrhage risk.

Neurofibrillary Tangles

  • Tau Protein:
    • Maintains microtubule structure in neurons.
    • Kinase activation due to plaques causes tau phosphorylation.
    • Tau becomes sticky, forming tangles inside neurons and disrupting signaling.
  • Effects on Neurons:
    • Neurons die, leading to brain atrophy, narrowed gyri, widened sulci, and enlarged ventricles.

Types of Alzheimer Disease

Sporadic Alzheimer Disease

  • Characteristics: Late-onset, with mixed genetic and environmental risk factors.
  • Prevalence: Increases with age—1% at 60-65 years, 50% over 85 years.
  • Risk Factor: APOE-e4 allele contributes to plaque formation.

Familial Alzheimer Disease

  • Characteristics: Early-onset, due to dominant gene mutations.
  • Prevalence: 5-10% of cases.
  • Genetic Causes:
    • PSEN-1 or PSEN-2 gene mutations affect gamma-secretase activity.
    • Trisomy 21 leads to increased APP expression in Down syndrome, accelerating plaque formation.

Progression of Symptoms

  • Early Stages: Difficulty detecting symptoms; short-term memory loss.
  • Middle Stages: Loss of motor skills, language difficulty, and long-term memory loss.
  • Advanced Stages: Disorientation, requiring full-time care, often leads to death by infection (e.g., pneumonia).

Diagnosis and Treatment

  • Diagnosis: Difficult; confirmed via brain biopsy post-autopsy.
  • Current Treatments:
    • No cure.
    • Existing medications provide limited benefits and do not stop disease progression.